Data include three late-breaking abstracts, underscoring Astellas' efforts to potentially redefine expectations for patients across its oncology portfolio
Read more at prnewswire.comAstellas to Share New Data Across Hard-to-Treat Cancers During ESMO Congress 2023
PR Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here